Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP993142priorityCriticalpatent/ECSP993142A/en
Publication of ECSP993142ApublicationCriticalpatent/ECSP993142A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
El invento se refiere a una composición farmacéutica que contiene ciclo -(Arg-Gli-Asp-D-Fen-Nme-Val) y/o una de sus sales aceptables desde el punto de vista fisiológico y al menos un compuesto quimioterapéutico y/o un inhibidor de la angiogénesis y/o una de sus sales aceptables desde el punto de vista fisiológico.The invention relates to a cyclo-containing pharmaceutical composition - (Arg-Gli-Asp-D-Fen-Nme-Val) and / or one of its physiologically acceptable salts and at least one chemotherapeutic compound and / or an angiogenesis inhibitor and / or one of its physiologically acceptable salts.
USE OF COMPOUNDS OF 1-AMINO-5-PHENYLPENTANE-3-OL AND / OR 1-AMINO-6-PHENYLHEXAN-3-OL FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH ANTAGONIST EFFECT OF N-METHYL-D-ASPARTATE- (NMDA)